AFFECTIVE DISORDERS--AN EXPLORATION OF LONG TERM COURSE
情感障碍——长期历程的探索
基本信息
- 批准号:2397735
- 负责人:
- 金额:$ 11.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1993
- 资助国家:美国
- 起止时间:1993-08-01 至 2001-07-31
- 项目状态:已结题
- 来源:
- 关键词:anxiety disorders bipolar depression clinical research computer data analysis data collection methodology /evaluation diagnosis quality /standard disease /disorder classification disease /disorder proneness /risk human data longitudinal human study major depression mental disorder diagnosis mental health epidemiology mood disorders personality tests prognosis psychosis relapse /recurrence schizophrenia social adjustment statistics /biometry
项目摘要
DESCRIPTION (Applicant's Abstract): Between 1978 and 1981, the NIMH
Collaborative Depression Study conducted thorough baseline evaluations of
955 probands with major affective disorder. Probands were followed at
semiannual and annual intervals to 10 years with a retention rate of 70.1%
of those still living. A further extension of this follow-up is currently
underway and a full 16-year follow-up will be available by the end of 1996.
The U01 grant for the extended follow-up, however, did not include support
for data analysis. Investigators at the Iowa Center obtained this through
the R01 mechanism and used the three years of support to produce 18 refereed
journal articles describing the course of affective illness over a 10-year
period. We now seek a competitive renewal to analyze data from the full 18
years. Earlier CDS analyses have emphasized the course of index episodes,
the time to subsequent clinical events, and the long-range prognostic
qualities of baseline measures. We have since shifted emphasis to the
timing and phenomenology of prospectively observed episodes and to overall
trends apparent across repeated observations. The prospective nature of the
available assessments provides unprecedented opportunities to describe the
long-term course of the major affective disorders without the biases
attending attempts to recall remote events. Moreover, newly available
statistical methods will allow the assessment of treatment effects on
morbidity and risk for suicide.
描述(申请人的摘要):在1978年和1981年之间,NIMH
协作抑郁症研究进行了全面的基线评估,
955例情感障碍先证者。 先证者随访时间为
每半年和每年一次,直至10年,留存率为70.1%
那些还活着的人。 目前正在进一步扩大这一后续行动,
到1996年底,将有一个完整的16年随访。
但是,用于延长后续行动的U01赠款不包括支助
用于数据分析。 爱荷华州中心的调查人员通过以下途径获得了这一结果:
R01机制,并利用三年的支持,
期刊文章描述了10年来情感性疾病的过程,
期 我们现在寻求一个有竞争力的更新,以分析数据,从整个18
年 早期的CDS分析强调了指数发作的过程,
至后续临床事件的时间和长期预后
基线测量的质量。 从那以后,我们把重点转移到了
前瞻性观察事件的时间和现象学,
重复观察的趋势明显。 未来的性质
现有的评估提供了前所未有的机会,
长期病程的主要情感障碍无偏见
试图回忆起遥远的事件。 此外,新提供的
统计学方法将允许评估治疗效果,
发病率和自杀风险。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
William Henry Coryell其他文献
William Henry Coryell的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('William Henry Coryell', 18)}}的其他基金
Cytokines, PUFA Tissue Concentrations and Treatment Selection in Antenatal MMD
产前 MMD 的细胞因子、PUFA 组织浓度和治疗选择
- 批准号:
8265810 - 财政年份:2011
- 资助金额:
$ 11.04万 - 项目类别:
Cytokines, PUFA Tissue Concentrations and Treatment Selection in Antenatal MMD
产前 MMD 的细胞因子、PUFA 组织浓度和治疗选择
- 批准号:
8028436 - 财政年份:2011
- 资助金额:
$ 11.04万 - 项目类别:
Pilot Study of Omega-3 Fatty Acid in Depressive Disorder
Omega-3 脂肪酸治疗抑郁症的初步研究
- 批准号:
7040784 - 财政年份:2004
- 资助金额:
$ 11.04万 - 项目类别:
A COLLABORATIVE GENOMIC STUDY OF BIPOLAR DISORDER
双相情感障碍的合作基因组研究
- 批准号:
2891158 - 财政年份:1998
- 资助金额:
$ 11.04万 - 项目类别:
A Collaborative Genomic Study of Bipolar Disorder
双相情感障碍的合作基因组研究
- 批准号:
6843721 - 财政年份:1998
- 资助金额:
$ 11.04万 - 项目类别:
A Collaborative Genomic Study of Bipolar Disorder
双相情感障碍的合作基因组研究
- 批准号:
7154081 - 财政年份:1998
- 资助金额:
$ 11.04万 - 项目类别:
相似海外基金
Psilocybin Assisted Psychotherapy for Bipolar Depression: An fMRI Emotional-Processing Pilot Study
裸盖菇素辅助双相抑郁心理治疗:功能磁共振成像情绪处理试点研究
- 批准号:
486939 - 财政年份:2023
- 资助金额:
$ 11.04万 - 项目类别:
Miscellaneous Programs
Repeated Ketamine Infusions for Cognitive Impairment in Treatment-Resistant Bipolar Depression
反复输注氯胺酮治疗难治性双相抑郁症的认知障碍
- 批准号:
486443 - 财政年份:2022
- 资助金额:
$ 11.04万 - 项目类别:
Studentship Programs
Reward and stress: Developing neuroimaging biomarkers for bipolar depression
奖励和压力:开发双相抑郁症的神经影像生物标志物
- 批准号:
2748645 - 财政年份:2022
- 资助金额:
$ 11.04万 - 项目类别:
Studentship
Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression: An Emotional-Processing fMRI Pilot Study
裸盖菇素对治疗难治性双相抑郁症的神经生物学作用:情绪处理功能磁共振成像初步研究
- 批准号:
486577 - 财政年份:2022
- 资助金额:
$ 11.04万 - 项目类别:
Studentship Programs
Theta-burst stimulation for bipolar depression: A randomized controlled trial
θ 爆发刺激治疗双相抑郁症:一项随机对照试验
- 批准号:
469571 - 财政年份:2022
- 资助金额:
$ 11.04万 - 项目类别:
Operating Grants
Cannabidiol Adjunctive Therapy for Acute Bipolar Depression: A Randomized Double-Blind Placebo Controlled Trial
大麻二酚辅助治疗急性双相抑郁症:随机双盲安慰剂对照试验
- 批准号:
444068 - 财政年份:2021
- 资助金额:
$ 11.04万 - 项目类别:
Operating Grants
Repeated Ketamine Infusions for Treatment-Resistant Bipolar Depression: A Randomized, Midazolam-Controlled Phase II Clinical Trial
重复氯胺酮输注治疗难治性双相抑郁症:一项随机、咪达唑仑对照的 II 期临床试验
- 批准号:
434675 - 财政年份:2020
- 资助金额:
$ 11.04万 - 项目类别:
Operating Grants
Next Generation Drugs for Bipolar Depression and Maintenance
治疗双相抑郁症和维持治疗的下一代药物
- 批准号:
9555300 - 财政年份:2018
- 资助金额:
$ 11.04万 - 项目类别:
Next generation drugs for bipolar depression and maintenance
用于双相抑郁症和维持治疗的下一代药物
- 批准号:
10080262 - 财政年份:2018
- 资助金额:
$ 11.04万 - 项目类别:
Next generation drugs for bipolar depression and maintenance
用于双相抑郁症和维持治疗的下一代药物
- 批准号:
10588254 - 财政年份:2018
- 资助金额:
$ 11.04万 - 项目类别: